TXG | tickerfilter.com

Fundamental analysis

22%

Profitability 4%

Dept financing 7%

Liquidity 75%

Performance 30%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

-0.60%

1 Month

14.40%

3 Months

4.19%

6 Months

-49.99%

1 Year

-54.70%

2 Year

-29.05%

Key data

Stock price

$23.38

P/E Ratio

-10.36

DAY RANGE

N/A - N/A

EPS

-$2.02

52 WEEK RANGE

$15.28 - $57.90

52 WEEK CHANGE

-$0.57

MARKET CAP

2.485 B

YIELD

N/A

SHARES OUTSTANDING

106.435 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/07/2024

BETA

2.12

PUBLIC FLOAT

AVERAGE 10 VOLUME

$1,435,572

AVERAGE 30 VOLUME

$1,681,484

Company detail

CEO: Serge Saxonov
Region: US
Website: https://www.10xgenomics.com/
Employees: 1,808
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services

advancing human health requires a greater understanding of biology, and that understanding starts with the cell. we enable researchers to drive exponential progress in oncology, immunology, neuroscience, and more with novel single cell, spatial, and in situ tools that have been cited in over 3,000 publications and continually improved by our dedicated scientific team. our aim: to develop innovative instruments, reagents, and software that allow you to see your biological system at a resolution that matches its complexity.

TXG - 10x Genomics Inc - Ordinary Shares - Class A